TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
Key Statistics
- 10–20% — Women of reproductive age with PCOS
- 2–5 nmol/L — Testosterone typical of PCOS
- >5 nmol/L — Testosterone — Investigate other cause
Don't-miss facts
-
PCOS testosterone 2–5 nmol/L; >5 nmol/L → investigate for tumour/other cause
-
Immunoassay can overestimate female testosterone by up to 100% – MS is gold standard but not widely available
-
Rotterdam: 2 of 3 – oligomenorrhoea/anovulation; clinical/biochemical hyperandrogenism; ovarian volume >10 ml on US – exclude other causes first
-
Ferriman-Gallwey ≥8 = hirsutism (11 sites, 0–4 scale)
-
Ovarian hyperthecosis: testosterone can exceed 7 nmol/L; main cause of postmenopausal hyperandrogenaemia
-
21-hydroxylase deficiency = 90–95% of CAH; non-classic form: 20–60% function, no salt-wasting, ~2% of female hyperandrogenism
-
Ovarian androgen tumour: ↑testosterone + normal DHEA-S/17-ketosteroids; adrenal tumour: not suppressed by dexamethasone
-
Gestational hyperandrogenism: rare, mostly luteoma/theca lutein cysts; solid unilateral lesion = ↑malignancy risk
Differential diagnoses (box 2)
PCOS Ovarian hyperthecosis CAH Cushing’s syndrome Androgen-secreting tumour Exogenous androgens
Gestational hyperandrogenism
Abbreviation Key
- PCOS — polycystic ovary syndrome
- LH — luteinising hormone
- DHEA — dehydroepiandrosterone
- FSH — follicle stimulating hormone
- DHEA-S — DHEA-sulfate
- GnRH — gonadotrophin releasing hormone
- SHBG — sex hormone binding globulin
- IGF-1 — insulin-like growth factor-1
- DHT — dihydrotestosterone
- AMH — anti-müllerian hormone
- CAH — congenital adrenal hyperplasia
- NASH — non-alcoholic steatohepatitis
- ACTH — adrenocorticotrophic hormone
- MS — mass spectrometry
- CRH — corticotrophin releasing hormone
- CT/MRI/US — computerised tomography / magnetic resonance imaging / ultrasound
Source: Meek CL et al. Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism. The Obstetrician & Gynaecologist 2013;15:171–176. doi:10.1111/tog.12030
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).